ARDD 2026 to Unite Longevity Science, Pharma and Regulation at Harvard
ARDD 2026, scheduled for October 1–3 at Harvard University, will convene scientists, pharmaceutical executives, regulators, investors and biotechnology leaders for ...
ARDD 2026, scheduled for October 1–3 at Harvard University, will convene scientists, pharmaceutical executives, regulators, investors and biotechnology leaders for ...
A Journal of Translational Medicine review outlines how mRNA-encoded antibodies, bispecific constructs, and transient CAR expression could overcome the manufacturing ...
A systematic review finds that only 34 of 753 studies on Brazil’s 71 RENISUS medicinal plants involved human trials, revealing ...
A comprehensive review maps how hydrogen-rich water is produced, why its dissolved hydrogen is so hard to keep, and what ...
A new perspective in Frontiers in Neurology argues that translated versions of the SARA and ICARS ataxia scales may not ...
A review in the Journal of Ovarian Research surveys clinical trial evidence on CAR-T, TCR-T, TIL and NK cell therapies, ...
A study in Cancer Causes & Control found that 46.2% of women contacting a breast cancer community-based organization expressed interest ...
A systematic review suggests probiotics may improve specific metabolic markers in heart disease patients, but the evidence is weak and ...
A critical review finds preliminary short-term efficacy signals and biologically coherent mechanisms for a Chinese five-material colon-targeted capsule in ulcerative ...
A methodology study developed and pilot-tested a six-element framework for defining clinical trial outcomes completely and consistently.
A narrative review links heat shock proteins to gastric cancer invasiveness, resistance and immune modulation, but finds that most therapeutic ...
A simulation study found that five of six Shigella vaccine trial designs could underestimate efficacy, particularly in high-burden settings with ...
A 2026 narrative review finds that genetically elevated lipoprotein(a) supports the onset of calcific aortic stenosis, but no completed trial ...
A 124-patient randomized trial will test whether probiotics reduce side effects and affect outcomes in advanced or recurrent ovarian cancer, ...
A 23-article collection reports advances in kidney cancer classification, prognosis and treatment while showing that prevention, early detection and prospective ...
A review finds that ARDS can be separated into hyperinflammatory and hypoinflammatory profiles, while also showing why combining blood biomarkers ...
A narrative review finds that multi-omics has not yet produced a validated test for selecting anti-obesity medication in people with ...
A National Cancer Institute grant will fund planned OU trials testing whether opaganib can enhance CAR T-cell activity against ultra-high-risk ...
A Roche-led benchmark found that the 10X Genomics GEM-X Flex assay with chop-fix processing improves single-cell RNA profiling of frozen ...
A randomized crossover trial found that zastaprazan’s orally disintegrating tablet delivers equivalent blood exposure with or without water while showing ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.